A natural lipopeptide of surfactin for oral delivery of insulin

References

• Carino GP, Jacob JS, Mathiowitz E. (2000). Nanosphere based oral insulin delivery. J Control Release 65:261–9
   PubMed Web of Science ®Google Scholar
• Carrillo C, Teruel JA, Aranda FJ, Ortiz A. (2003). Molecular mechanism of membrane permeabilization by the peptide antibiotic surfactin. Biochim Biophys Acta 1611:91–7
   PubMed Web of Science ®Google Scholar
• Cherrington AD, Neal DW, Edgerton DS, et al. (2004). Inhalation of insulin in dogs: assessment of insulin levels and comparison to subcutaneous injection. Diabetes 53:877–81
   PubMed Web of Science ®Google Scholar
• Damgé C, Maincent P, Ubrich N. (2007). Oral delivery of insulin associated to polymeric nanoparticles in diabetic rats. J Control Release 117:163–70
   PubMed Web of Science ®Google Scholar
• Deleu M, Lorent J, Lins L, et al. (2013). Effects of surfactin on membrane models displaying lipid phase separation. Biochim Biophys Acta 1828:801–15
   PubMed Web of Science ®Google Scholar
• Furtado S, Abramson D, Burrill R, et al. (2008). Oral delivery of insulin loaded poly(fumaric-co-sebacic) anhydride microspheres. Int J Pharm 347:149–55
   PubMed Web of Science ®Google Scholar
• Gao Z, Zhao X, Lee S, et al. (2013). WH1fungin a surfactin cyclic lipopeptide is a novel oral immunoadjuvant. Vaccine 31:2796–803
   PubMed Web of Science ®Google Scholar
• Gaofu Q, Shiqing M, Fayin Z, et al. (2008). In vitro assessment of plant lectins with anti-pinwood nematode activity. J Invertebr Pathol 98:40–5
   PubMed Web of Science ®Google Scholar
• Huang YC, Lin YM, Chang TW, et al. (2007). The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity. J Biol Chem 282:4626–33
   PubMed Web of Science ®Google Scholar
• Hwang YH, Kim MS, Song IB, et al. (2009). Subacute (28 day) toxicity of Surfactin C, a lipopeptide produced by Bacillus subtilis, in rats. J Health Sci 55:351–5
   Google Scholar
• Jain A, Jain SK. (2015). L-Valine appended PLGA nanoparticles for oral insulin delivery. Acta Diabetol 52:663–76
   PubMed Web of Science ®Google Scholar
• Jintapattanakit A, Junyaprasert VB, Mao S, et al. (2007). Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharm 342:240–9
   PubMed Web of Science ®Google Scholar
• Kanzarkar M, Pathak PP, Vaidya M, et al. (2015). Oral insulin delivery system for diabetes mellitus. Pharm Pat Anal 4:29–36
   PubMed Web of Science ®Google Scholar
• Katsuma M, Watanabe S, Kawai H, et al. (2006). Effects of absorption promoters on insulin absorption through colon-targeted delivery. Int J Pharm 307:156–62
   PubMed Web of Science ®Google Scholar
• Kim JK, Lee SA, Shin S, et al. (2010a). Structural flexibility and the positive charges are the key factors in bacterial cell selectivity and membrane penetration of peptoid-substituted analog of Piscidin 1. Biochim Biophys Acta 1798:1913–25
   PubMed Web of Science ®Google Scholar
• Kim SK, Lee S, Jin S, et al. (2010b). Diabetes correction in pancreatectomized canines by orally absorbable insulin-deoxycholate complex. Mol Pharm 7:708–17
   PubMed Web of Science ®Google Scholar
• Li X, Guo S, Zhu C, et al. (2013). Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Biomaterials 34:9678–87
   PubMed Web of Science ®Google Scholar
• Li P, Tan A, Prestidge CA, et al. (2014). Self-nanoemulsifying drug delivery systems for oral insulin delivery: in vitro and in vivo evaluations of enteric coating and drug loading. Int J Pharm 477:390–8
   PubMed Web of Science ®Google Scholar
• Liu J, Zou A, Mu B. (2010). Toluidine blue: aggregation properties and distribution behavior in surfactin micelle solution. Colloids Surf B Biointerfaces 75:496–500
   PubMed Web of Science ®Google Scholar
• Ma E, Ma H, Liu Z, et al. (2006). In vitro and in vivo evaluation of a novel oral insulin formulation. Acta Pharmacol Sin 27:1382–8
   PubMed Web of Science ®Google Scholar
• Makhlof A, Tozuka Y, Takeuchi H. (2011). Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 42:445–51
   PubMed Web of Science ®Google Scholar
• Mansourpour M, Mahjub R, Amini M, et al. (2015). Development of acid-resistant alginate/trimethyl chitosan nanoparticles containing cationic β-cyclodextrin polymers for insulin oral delivery. AAPS PharmSciTech 16:952–62
   PubMed Web of Science ®Google Scholar
• Nordestgaard BG, Agerholm-Larsen B, Stender S. (1997). Effect of exogenous hyperinsulinaemia on atherogenesis in cholesterol-fed rabbits. Diabetologia 40:512–20
   PubMed Web of Science ®Google Scholar
• Pan Y, Li Y, Zhao H, et al. (2002). Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int J Pharm 249:139–47
   PubMed Web of Science ®Google Scholar
• Qi G, Zhu F, Du P, et al. (2010). Lipopeptide induces apoptosis in fungal cells by a mitochondria-dependent pathway. Peptides 31:1978–86
   PubMed Web of Science ®Google Scholar
• Ramkissoon-Ganorkar C, Liu F, Baudys M, Kim SW. (1999). Modulating insulin-release profile from pH/thermosensitive polymeric beads through polymer molecular weight. J Control Release 59:287–98
   PubMed Web of Science ®Google Scholar
• Rekha MR, Sharma CP. (2009). Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption. J Control Release 135:144–51
   PubMed Web of Science ®Google Scholar
• Sajeesh S, Bouchemal K, Marsaud V, et al. (2010). Cyclodextrin complexed insulin encapsulated hydrogel microparticles: an oral delivery system for insulin. J Control Release 147:377–84
   PubMed Web of Science ®Google Scholar
• Shaligram NS, Singhal RS. (2010). Surfactin – a review on biosynthesis, fermentation, purification and applications. Food Technol Biotechnol 48:119–34
   Web of Science ®Google Scholar
• Shi K, Fang Y, Kan Q, et al. (2015). Surface functional modification of self-assembled insulin nanospheres for improving intestinal absorption. Int J Biol Macromol 74:49–60
   PubMed Web of Science ®Google Scholar
• Sonaje K, Lin YH, Juang JH, et al. (2009). In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 30:2329–39
   PubMed Web of Science ®Google Scholar
• Sonaje K, Chen YJ, Chen HL, et al. (2010). Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials 31:3384–94
   PubMed Web of Science ®Google Scholar
• Sonia TA, Sharma CP. (2013). In vitro evaluation of quaternized polydimethylaminoethylmethacrylate sub-microparticles for oral insulin delivery. J Biomater Appl 28:62–73
   PubMed Web of Science ®Google Scholar
• Sonia TA, Rekha MR, Sharma CP. (2011). Bioadhesive hydrophobic chitosan microparticles for oral delivery of insulin: in vitro characterization and in vivo uptake studies. J Appl Polym Sci 119:2902–10
   Web of Science ®Google Scholar
• Surendrakumar K, Martyn GP, Hodgers EC, et al. (2003). Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J Control Release 91:385–94
   PubMed Web of Science ®Google Scholar
• Yin L, Ding J, He C, et al. (2009). Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 30:5691–700
   PubMed Web of Science ®Google Scholar
• Zhang J, Liu D, Huang Y, et al. (2012). Biopharmaceutics classification and intestinal absorption study of apigenin. Int J Pharm 436:311–17
   PubMed Web of Science ®Google Scholar
• Zou A, Liu J, Garamus VM, et al. (2010). Interaction between the natural lipopeptide [Glu1,) Asp5)] surfactin-C15 and hemoglobin in aqueous solution. Biomacromolecules 11:593–9
   PubMed Web of Science ®Google Scholar